medigraphic.com
ISSN 1561-2937 (Print)

2021, Number 3

<< Back

Rev Cubana Cardiol Cir Cardiovasc 2021; 27 (3)

History and evolution of hemodynamics and interventional cardiology

Obregón SÁG, Aroche AR, López FL, Aldama PLI, Aguilar MJM, Vila GEE

Language: Spanish
References: 55
Page: 1-9
PDF size: 417.15 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Forssmann W. The catheterization of the right side of the Heart. Klin Wochenschr 1929; 8: 2085-9.

  2. Klein O. Determining human cardiac output (minute volume) using Fick’s principle (extraction of mixed venous blood by cardiac catheterization) Med Wochenschr 1930; 77:1311-5.

  3. Castellanos A, Pereiras R., Garcia A. Counter-Part aortography. Rev Cuban Cardiol 1939; 2:187-9.

  4. Cournand A , Ranges HA. Catheterization of the right auricle in man. Proc Soc Exp Biol Med 1941; 46: 462.

  5. Brannon ES, Weens HS, Warren JW, Atrial septal defect: Study of hemodynamics by the technique of right heart catheterization. Am J Med Sci 1945; 210:480- 9.

  6. Zimmerman HA, Scott RW, Becker NO. Catheterization of the left side of the heart in man. Circulation 1950; 1-357-61.

  7. Dotter CT, Frische LH. Visualization of the coronary circulation by occlusion aortography: a practical method. Radiology 1958; 76:502-7.

  8. Arnulf G, Chacornac R. Communication to La Société de Chirurgie de Lyon, Novembre 14, 1957, in Arnulf G. L’artériographie méthodique des artères coronaries grâce a l’utilisation de l’acétylcholine: Données expérimentales et cliniques. Bull Acad Natl Med (Paris) 1958 ; 25/26 :661-3.

  9. Richard LS, Thal AP. Phasic dye injection control system for coronary arteriography in the human. Surg Gynecol Obstet 1958; 107:739-43.

  10. Nordenstrom B. Contrast examination of the cardiovascular system during increased intrabronchial pressure. Acta Radiol1960; 200 Suppl: 110-5.

  11. Bilgutay AM, Gannon P, Sterns LP. Ferlic R, Lillehei CW. Coronary arteriography: New method under induced hypotension by pacing_ experimental and clinical application. Arch Surg 1964; 89:899-01.

  12. Bellman S, Frank HA, Lambert PB, Littman D, Williams JA. Coronary arteriography: I. Differential opacification of the aortic stream catheters of special design: Experimental development. N Engl J Med 1960; 262:325-9.

  13. Sones FM. Coronary arteriography. Read before the Eighth Annual Convention of the American College of Cardiology, Philadelphia, 1959.

  14. Dotter CT, Judkins MP. Transluminal treatment of atherosclerotic obstruction: Description of a new technique and preliminary report of its application. Circulation 1964; 30:654-8.

  15. Dotter CT, Rosch J, Judkins MP. Transluminal dilatation of atherosclerotic stenosis. Surg Gynecol Obstet 1968; 127:794-8.

  16. Gruentzig AR, Turina M, Schneider J. Experimental percutaneous dilatation of coronary artery stenosis. Circulation Suppl 1976; 54:81-5.

  17. Hurst J.W. History of cardiac catheterization. In. King SB III, Douglas JS editors. Coronary Arteriography and Angioplasty. New York: Mc Graw - Hill 1985.p.1-9.

  18. Busch U, Erbel R, Clas W. Verbersserete Okklusiontoleranzzeit durch Kontinuierliche Koronarperfusion mit modifiziertem. Gruentzig-Koronarangioplastiekatheter Z. Kardiol 1985; 74: 435-9.

  19. Van Tassel RA, Gobel FL, Rydel MA, Vlodaver Z, McCarter DJ. A less traumatic catheter for coronary arteriography. Cathet Cardiovasc Diagn 1985;11:187-99

  20. Bonzel TR, Wollschlager H, Just H. Ein neves kathetersystem zur mechanischen dilatation von koronarstenosen mit austauschbaren intra koronaren kathetern, hoherenn kontrastmi ttelfluss und verbesserter steverbarkeit. Biomed Technn. 1986:31; 195-200.

  21. Meyer J, Merx W. Schmitz H. Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation 1982; 66:905-13.

  22. Hartzler GO. Rutherford BD, Mc Conahay DR. Percutaneous transluminal coronary angioplasty with and without thrombotic therapy for treatment of acute myocardial infarctions. Am. Heart J 1983;106 : 965-71.

  23. Simpson JB, Johnson DE, Thapliyal HV. Transluminal atherectomy: a new approach to the treatment of atherosclerotic vascular disease. Circulation 1985; 72:146-53.

  24. Ritchie J, Hansen D, Urocko R. Auth D. Mechanical thrombolysis: A new rotational catheter approach for acute thrombi. Circulation 1986; 73:1006-12.

  25. Litvack F, Groundfest W, Goldenberg T. Laudenslagert J. Forrester J. Percutaneous excimer laser angioplasty of aortocoronary saphenous vein grafts J Am Coll Cardiol 1989: 14: 803-8.

  26. King III SB, Yeh W, Hulubkou R, Baim DS, Sopko G, Holmes D. Balloon angioplasty versus new device intervention clinical outcomes. J Am Coll Cardiol 1998; 31: 558-66.

  27. Mulliken JB, Goldwyn RM. Impressions of Charles Stent. Plastic Reconst Surg, 1978; 62:173-6.

  28. Palmaz JC, Sibbit RR, Reuter SR, Rice W. Expandable intraluminal graft: a preliminar study radiology;1985 156:73-7.

  29. Roubin GS, Robinson KA, King SB III, Gianturco C, Black AJ, Brown JE, et al. Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs. Circulation; 1987:891-97.

  30. Kuntz, RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 1993; 21:15-25.

  31. Puel J, Joffre F, Rousseau H, Guermunprez B, Lancelin B, Morice MC. Endoprothéses coronariennes auto - expansives dans le prévention des restenoses après angioplastie transluminale. Arch. Mal. Coeur1987 ; 8 : 1311-2.

  32. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987; 316:701-6.

  33. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, et al. Clinical experience with the Palmaz-Schatz coronary stent: Initial results of a multicenter study. Circulation 1991; 83:148-61.

  34. Roubin GS, Cannon Ad, Agrawal SK, Macander PJ, Dean LS, Baxley WA, Breland J, Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992; 85: 916-27.

  35. Barragan P, Sainson J, Silvestri M . Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn 1994; 32:133-8.

  36. Colombo A, Hall P, Nakamura S. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91:1676-88.

  37. Chornos NA, Robinson KA, Nelly AB. Thromboresistant phosphorylcholine coating for coronary stent. Circulation 1995; 92(suppl I):1-685.

  38. Foerst J, Vorpahl M, Engelhardt M, Koehler T, Tiroch K, Wessely R. Evolution of Coronary Stents: From Bare-Metal Stents to Fully Biodegradable, Drug-Eluting Stents. Comb Prod Ther. 2013;3(1–2):9–24. https://link.springer.com/article/10.1007/s13556-013-0005-7

  39. Burke SE, Lubbers NL, Chen YW. Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin. J Cardiovasc Pharmacol 1999; 33:829-35.

  40. Morice MD, Serruys PW, Sousa JE, Fajadet J, Banhayashi E, Perin M. et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773-80.

  41. Kirtane AJ, Leon MB, Ball MW et al. The final 5 year follow up from the ENDEAVOUR IV Trial comparing a Zotarolimus eluting stent with a paclitaxel eluting stent. JACC Cardiovasc Interv. 2013; 6:325-333.

  42. Rober L, Magro M, Stefanini GG, et al. Very late coronary stent thrombosis of a newer-generation everolimus eluting stent compared with early-generation drug-eluting stents. A prospective cohort study. Circulation 2012; 125:1110-1121.

  43. Hu T, Yang J, Cui K, Rao Q, Yin T, Tan L, et al. Controlled Slow-Release Drug-Eluting Stents for the Prevention of Coronary Restenosis: Recent Progress and Future Prospects. ACS Appl Mater Interfaces. 2015;7(22):11695–11712. https://www. ncbi.nlm.nih.gov/pubmed/26011753

  44. 16. Chen W, Habraken T, Hennink WE, Kok RJ. Polymer-free drug-eluting stents : an overview of coating strategies and comparison with polymer-coated drug-eluting stents Polymer-free drug-eluting stents : an overview of coating strategies and comparison with polymer-coated drug-eluting stents. Bioconjug Chem. 2015;26(7):1277–1288.

  45. Muramatsu T, Onuma Y, Zhang Y-J, Bourantas C V, Kharlamov A, Diletti R, et al. Progress in treatment by percutaneous coronary intervention: the stent of the future. Rev española Cardiol. 2013;66(6):483–96. https://www.ncbi.nlm.nih.gov/ pubmed/24776051

  46. Echeverri D, Cabrales JR. Terapia de restauración vascular con plataformas biorreabsorbibles. La cuarta revolución. Rev Colomb Cardiol . Sociedad Colombiana de Cardiología y Cirugía Cardiovascular; 2014;21(4):231–40.

  47. Iqbal J, Gunn J, Serruys PW. Coronary stents: Historical development, current status and future directions. Br Med Bull. 2013;106:193–211. https://www.ncbi. nlm.nih.gov/pubmed/23532779.

  48. Campos CM, Muramatsu T, Iqbal J, Zhang YJ, Onuma Y, Garcia-Garcia HM, et al. Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease. Int J Mol Sci. 2013;14:24492–500. http://www.mdpi.com/14220067/14/12/24492.

  49. Bourantas C V., Onuma Y, Farooq V, Zhang Y, Garcia-Garcia HM, Serruys PW. Bioresorbable scaffolds: Current knowledge, potentialities and limitations experienced during their first clinical applications. Int J Cardiol . Elsevier Ireland Ltd; 2013;167(1):11–21. https://www.ncbi.nlm.nih.gov/pubmed/22748288

  50. Simard T, Hibbert B, Ramirez FD, Froeschl M, Chen Y-X, O’Brien ER. The evolution of coronary stents: a brief review. Can J Cardiol . Canadian Cardiovascular Society; 2014;30(1):35–45. https://www.ncbi.nlm.nih.gov/pubmed/24286961

  51. Obregón Santos AG, Aroche Aportela R, Aldama Pérez L, Navas Hernández M, Vila García EE. Ecografía Intracoronaria. Rev Cardiología y Cirugía Cardiovascular 2011;23:3:340-44´

  52. Bach RG, Donohue TJ, Kern MJ, Intracoronary doppler flow velocity measurements for the evaluation and treatment of coronary artery disease. Curr Opin Cardiol 1995; 10:434-42.

  53. Macias E, Medina MA, Gonzalo N, Escaned J. Tomografía de coherencia óptica. Bases y aplicaciones de una nueva técnica de imagen intravascular. Arch Cardiol Mex, 2013;83(2):112-119.

  54. Unzué L et al. Estudio de lesiones coronarias por segmentos mediante TCMD: correlación con el análisis cuantitativo por coronariografía invasiva. Rev Esp Cardiol 2020. https://doi.org/10.1016/j.recesp.2020.04.024.

  55. Palacios IF, Arzamendi, D, Intervencionismo en cardiopatía estructural. Más allá de la terapia valvular transcatéter. Rev. Esp.Cardiol. 2012;65(5):405-413




2020     |     www.medigraphic.com